<?xml version="1.0" encoding="UTF-8"?>
<p>In the early stage of the COVID-19 outbreak in Wuhan, researchers isolated the virus from infected pneumonia patients and characterized the pathogen using metagenomic next-generation sequencing (mNGS) and electron microscopy.
 <sup>
  <xref ref-type="bibr" rid="ref8">8</xref>,
  <xref ref-type="bibr" rid="ref9">9</xref>
 </sup> SARS-CoV-2 is a pathological nanoparticle composed essentially of protein and RNA. The first draft of the SARS-CoV-2 genome was released on January 10, 2020 (GenBank: MN908947). The SARS-CoV-2 genome is 29,891 nucleotides in length, encoding 9,860 amino acids that are homologous to lineage B Î²-CoVs.
 <sup>
  <xref ref-type="bibr" rid="ref8">8</xref>,
  <xref ref-type="bibr" rid="ref10">10</xref>,
  <xref ref-type="bibr" rid="ref11">11</xref>
 </sup> SARS-CoV-2 is 96.3% homologous to BatCoV RaTG13 but discordant with SARS-CoV-1 and MERS-CoV.
 <sup>
  <xref ref-type="bibr" rid="ref12">12</xref>
 </sup>
</p>
